INOVIO PHARMACEUTICALS, INC. Licenses Revenue (Deprecated 2018-01-31)
INOVIO PHARMACEUTICALS, INC. (INO) reported Licenses Revenue (Deprecated 2018-01-31) of $1.29 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Income Statement › Other Income
us-gaap:LicensesRevenue · last filed 2018-05-09
- INOVIO PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.29M, a 69.94% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $351.27K, a 84.91% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $16.36M, a 765.52% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $4.29M, a 138.67% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2012 was $82.54K, a 47.23% decline from fiscal 2011.
- INOVIO PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2011 was $156.40K, a 26.89% decline from fiscal 2010.
- INOVIO PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2010 was $213.92K, a 95.66% decline from fiscal 2009.
- INOVIO PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2009 was $4.93M.
| Period end | Licenses Revenue (Deprecated 2018-01-31) 3 month | Licenses Revenue (Deprecated 2018-01-31) 3 month as first filed | Licenses Revenue (Deprecated 2018-01-31) 6 month | Licenses Revenue (Deprecated 2018-01-31) 9 month | Licenses Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $1.29M 10-Q · filed 2018-05-09 | ||||
| 2017-09-30 | $351.27K 10-Q · filed 2017-11-08 | $16.71M derived: sum of 2 quarters · filed 2017-11-08 | $21.00M 10-Q · filed 2017-11-08 | ||
| 2017-06-30 | $16.36M 10-Q · filed 2017-08-08 | $20.65M 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | $4.29M 10-Q · filed 2018-05-09 | ||||
| 2016-09-30 | $2.33M 10-Q · filed 2017-11-08 | $4.22M derived: sum of 2 quarters · filed 2017-11-08 | $6.01M 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $1.89M 10-Q · filed 2017-08-08 | $3.69M 10-Q · filed 2017-08-08 | |||
| 2016-03-31 | $1.80M 10-Q · filed 2017-05-10 | ||||
| 2015-09-30 | $16.48M 10-Q · filed 2016-11-09 | $20.81M derived: sum of 2 quarters · filed 2016-11-09 | $25.06M 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $4.34M 10-Q · filed 2016-08-08 | $8.58M 10-Q · filed 2016-08-08 | |||
| 2015-03-31 | $4.25M 10-Q · filed 2016-05-09 | ||||
| 2014-09-30 | $1.11M 10-Q · filed 2015-11-09 | $4.22M derived: sum of 2 quarters · filed 2015-11-09 | $5.66M 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $3.11M 10-Q · filed 2015-08-10 | $4.54M 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | $1.44M 10-Q · filed 2015-05-11 | ||||
| 2013-09-30 | $8.39M 10-Q · filed 2014-11-10 | $8.40M derived: sum of 2 quarters · filed 2014-11-10 | $8.42M 10-Q · filed 2014-11-10 | $8.54M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | $14.31K 10-Q · filed 2014-08-11 | $28.57K 10-Q · filed 2014-08-11 | $149.12K derived: sum of 3 quarters · filed 2014-08-11 | $171.61K derived: sum of 4 quarters · filed 2014-08-11 | |
| 2013-03-31 | $14.26K 10-Q · filed 2014-05-12 | $134.81K derived: sum of 2 quarters · filed 2014-05-12 | $157.30K derived: sum of 3 quarters · filed 2014-05-12 | $178.21K derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $120.55K 10-K · filed 2013-03-18 | $143.04K derived: sum of 2 quarters · filed 2013-11-12 | $163.95K derived: sum of 3 quarters · filed 2013-11-12 | $82.54K 10-K · filed 2013-03-18 | |
| 2012-09-30 | $22.50K 10-Q · filed 2013-11-12 | $43.40K derived: sum of 2 quarters · filed 2013-11-12 | $68.24K 10-Q · filed 2013-11-12 | $201.18K derived: sum of 4 quarters · filed 2013-11-12 | |
| 2012-06-30 | $20.91K 10-Q · filed 2013-08-09 | $45.74K 10-Q · filed 2013-08-09 | $178.68K derived: sum of 3 quarters · filed 2013-08-09 | $361.82K derived: sum of 4 quarters · filed 2013-08-09 | |
| 2012-03-31 | $24.84K 10-Q · filed 2013-05-10 | $157.77K derived: sum of 2 quarters · filed 2013-05-10 | $340.91K derived: sum of 3 quarters · filed 2013-05-10 | $472.58K derived: sum of 4 quarters · filed 2013-05-10 | |
| 2011-12-31 | $132.94K 10-K · filed 2013-03-18 | $316.07K derived: sum of 2 quarters · filed 2013-03-18 | $447.74K derived: sum of 3 quarters · filed 2013-03-18 | $156.40K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $183.14K 10-K · filed 2013-03-18 | $76.89K 10-Q · filed 2011-11-07 | $314.80K derived: sum of 2 quarters · filed 2013-03-18 | $129.71K 10-Q · filed 2012-11-07 | $487.01K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $131.66K 10-K · filed 2013-03-18 | $26.46K 10-Q · filed 2011-08-05 | $52.82K 10-Q · filed 2012-08-09 | $303.87K derived: sum of 3 quarters · filed 2013-03-18 | $343.20K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $120.12K 10-K · filed 2013-03-18 | $26.37K 10-Q · filed 2012-05-09 | $172.21K derived: sum of 2 quarters · filed 2013-03-18 | $211.54K derived: sum of 3 quarters · filed 2013-03-18 | $267.48K derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $52.09K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $91.42K derived: sum of 2 quarters · filed 2013-03-18 | $147.36K derived: sum of 3 quarters · filed 2013-03-18 | $213.92K 10-K · filed 2013-03-18 | |
| 2010-09-30 | $39.33K 10-Q · filed 2011-11-07 | $95.27K derived: sum of 2 quarters · filed 2011-11-07 | $161.82K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $55.94K 10-Q · filed 2011-08-05 | $122.50K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $4.93M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |